ORIGINAL RESEARCH
Published on 22 Sep 2025
Dual-edged mechanisms of α-tomatine in hepatocellular carcinoma by suppression of Wnt/β-catenin signaling versus RelB-Driven resistance in tumor therapy
doi 10.3389/fphar.2025.1616975
- 1,282 views
- 1 citation
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- CRISPR/Cas9 in Cancer: Pioneering Gene Editing for Enhanced Drug Discovery
CRISPR/Cas9 in Cancer: Pioneering Gene Editing for Enhanced Drug Discovery
3,952
Total downloads
26k
Total views and downloads
Articles
REVIEW
Published on 08 Jul 2025
CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects
doi 10.3389/fphar.2025.1552741
- 5,229 views
- 3 citations
ORIGINAL RESEARCH
Published on 20 Sep 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of in-vivo CRISPR-Cas therapy
doi 10.3389/fphar.2024.1454785
- 5,887 views
- 9 citations
ORIGINAL RESEARCH
Published on 05 Dec 2019
Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
doi 10.3389/fphar.2019.01456
- 6,463 views
- 27 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Pharmacogenetics and Pharmacogenomics
Experimental Pharmacology and Drug Discovery
Other participating journals
Frontiers in Genetics
- 2.8 impact factor
- 6.2 citescore
Frontiers in Genome Editing
- 4.4 impact factor
- 9.5 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore